Fig. 1From: The efficacy and safety of intravesical chondroitin sulphate solution in recurrent urinary tract infectionsAssessment of infection rates expressed as number of infections in rUTI patients 12 months before treatment and after 12 months of treatment. Illustrated are mean events of infections per group; CS (n = 50, black bars), LDLTABCS (n = 50, grey bars), LDLTAB (n = 51, white bars); ***p < 0.00001Back to article page